Systemic markers of inflammation in stable bronchiectasis

European Respiratory Journal

Volumn 12, Issue 4, 1998, Pages 820-824

  Wilson, C B ^a   Jones, P W ^b   O'Leary, C J ^b   Hansell, D M ^c   Dowling, R B ^a   Cole, P J ^a   Wilson, R ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Bronchiectasis; Inflammation; Quality of life

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTICLE; BRONCHIECTASIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL; QUALITY OF LIFE;

ADULT; AGED; ANALYSIS OF VARIANCE; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; BRONCHIECTASIS; FEMALE; HUMANS; IMMUNOGLOBULINS; INCIDENCE; INFLAMMATION; MALE; MIDDLE AGED; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031722626     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12040820     Document Type: Article

References (22)

1. Cole PJ. Bronchiectasis. In: Brewis RAL, Corrin B, Geddes DM, Gibson GJ, eds. Respiratory Medicine, 2nd Edn. Vol. 2. London, W.B. Saunders Co., 1995; pp. 1286-1316.
2. Cole PJ. Inflammation: a two-edged sword - the model of bronchiectasis. Eur J Respir Dis 1986; 69: Suppl. 147, 6-15.
3. Cole PJ, Wilson R. Host-microbial interrelationships in respiratory infection. Chest 1989; 95: 217-221.
4. Ip M, Shum D, Lauder I, Lam WK, So SY. Effect of antibiotics on sputum inflammatory contents in acute exacerbations of bronchiectasis. Respir Med 1993; 87: 449-454.
5. Hill SL, Burnett D, Hewetson KA, Stockley RA. The response of patients with purulent bronchiectasis to antibiotics for four months. Q J Med 1988; 66: 163-173.
6. Valletta EA, Rigo A, Bonazzi L, Zanolla L, Mastella G. Modification of some markers of inflammation during treatment for acute respiratory exacerbation in cystic fibrosis. Acta Paediatr 1992; 81: 227-230.
7. Smith RP, Lipworth BJ, Cree IA, Spiers EM, Winter JH. C-reactive protein. A clinical marker in community-acquired pneumonia. Chest 1995; 108: 1288-1291.
8. Konstan MW, Hilliard KA, Norvell TM, Berger M. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 1994; 150: 448-454.
9. Elborn JS, Cordon SM, Parker D, Delamere FM, Shale DJ. The host inflammatory response prior to death in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection. Respir Med 1987; 87: 603-607.
10. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-1327.
11. Bousquet J, Knani H, Dhivert A, et al. Quality of life in asthma: I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med 1994; 149: 371-375.
12. Chandler T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res 1993; 37: 147-153.
13. Miszkiel KA, Wells AU, Rubens MB, Cole PJ, Hansell DM. The effects of airway colonization by Pseudomonas aeruginosa: a CT study. Thorax 1997; 52: 260-264.
14. Reiff DB, Wells AU, Carr DH, Cole PJ, Hansell DM. CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. Am J Roentgenol 1995; 2: 261-267.
15. Wilson CB, Jones P, O'Leary C, Cole PJ, Wilson R. Validation of the St. George's Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med 1997; 156: 536-541.
16. Jones PW. Issues concerning health-related quality of life in COPD. Chest 1995; 107: Suppl., 187-193.
17. Stockley RA, Shaw J, Hill SL, Burnett D. Neutrophil chemotaxis in bronchiectasis: a study of peripheral cells and lung secretions. Clin Sci 1988; 74: 645-650.
18. Ip M, Lauder IJ, Wong WY, So SY. Multivariate analysis of factors affecting pulmonary function in bronchiectasis. Respiration 1993; 60: 45-50.
19. Fagon JY, Chastre J, Trouillet JL, et al. Characterisation of distal bronchial microflora during acute exacerbations of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis 1990; 142: 1004-1008.
20. Haynes C, Jones P, O'Leary C, et al. Comparison of quality of life measures, physiological measures, and extent of disease measured by CT scan in bronchiectasis. Thorax 1995; 50: A27.
21. Guyatt GH, Thompson PJ, Berman LB, et al. How should we measure function in patients with chronic heart and lung diseases? J Chronic Dis 1985; 38: 517-524.
22. Currie DC, Peters AM, Garbett ND, et al. Indium-111-labelled granulocyte scanning to detect inflammation in the lungs of patients with chronic sputum expectoration. Thorax 1990; 45: 541-544.